Literature DB >> 23866974

Probiotics from research to market: the possibilities, risks and challenges.

Benoit Foligné1, Catherine Daniel, Bruno Pot.   

Abstract

Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scientific support. Today, probiotics are mainly used for gastrointestinal applications, their use can easily be extended to skin, oral and vaginal health. While most probiotics currently belong to food-grade species, the future may offer new functional microorganisms in food and pharma. This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23866974     DOI: 10.1016/j.mib.2013.06.008

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  32 in total

Review 1.  Recent Advances in the Physiology of Spore Formation for Bacillus Probiotic Production.

Authors:  Vladimir Elisashvili; Eva Kachlishvili; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

Review 2.  Topical use of probiotics: The natural balance.

Authors:  Freni Kekhasharú Tavaria
Journal:  Porto Biomed J       Date:  2017-05-01

Review 3.  Use of probiotics in the fight against Helicobacter pylori.

Authors:  Paolo Ruggiero
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

4.  Dual-Color Bioluminescence Imaging for Simultaneous Monitoring of the Intestinal Persistence of Lactobacillus plantarum and Lactococcus lactis in Living Mice.

Authors:  Catherine Daniel; Sabine Poiret; Véronique Dennin; Denise Boutillier; Delphine Armelle Lacorre; Benoit Foligné; Bruno Pot
Journal:  Appl Environ Microbiol       Date:  2015-05-29       Impact factor: 4.792

5.  Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.

Authors:  Petra Zadravec; Borut Štrukelj; Aleš Berlec
Journal:  Appl Environ Microbiol       Date:  2015-01-09       Impact factor: 4.792

6.  Protective Effect of Levilactobacillus brevis Against Yersinia enterocolitica Infection in Mouse Model via Regulating MAPK and NF-κB Pathway.

Authors:  Ziqi Shi; Naiyu Guan; Weijiao Sun; Tianzhi Sun; Lingdi Niu; Jinyu Li; Junwei Ge
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-04       Impact factor: 5.265

Review 7.  Dietary strategies for the treatment of cadmium and lead toxicity.

Authors:  Qixiao Zhai; Arjan Narbad; Wei Chen
Journal:  Nutrients       Date:  2015-01-14       Impact factor: 5.717

Review 8.  A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe.

Authors:  Sylvie Miquel; Martin Beaumont; Rebeca Martín; Philippe Langella; Véronique Braesco; Muriel Thomas
Journal:  Microb Cell Fact       Date:  2015-04-09       Impact factor: 5.328

Review 9.  Biopolymers from lactic acid bacteria. Novel applications in foods and beverages.

Authors:  María I Torino; Graciela Font de Valdez; Fernanda Mozzi
Journal:  Front Microbiol       Date:  2015-09-11       Impact factor: 5.640

10.  In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice.

Authors:  Aleš Berlec; Janja Završnik; Miha Butinar; Boris Turk; Borut Štrukelj
Journal:  Microb Cell Fact       Date:  2015-11-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.